You have 9 free searches left this month | for more free features.

elx-02

Showing 1 - 8 of 8

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Alport Syndrome Trial in Clayton, Parkville, London (ELX-02)

Recruiting
  • Alport Syndrome
  • ELX-02
  • Clayton, Victoria, Australia
  • +3 more
Dec 19, 2022

Cystic Fibrosis Trial in Canada, United States (ELX-02, Ivacaftor)

Recruiting
  • Cystic Fibrosis
  • Long Beach, California
  • +9 more
Feb 15, 2022

Cystic Fibrosis Trial in Australia, Germany, Israel (ELX-02, Ivacaftor)

Recruiting
  • Cystic Fibrosis
  • Camperdown, New South Whales, Australia
  • +8 more
Feb 15, 2022

Impaired Renal Function Trial in Miami (ELX-02)

Completed
  • Impaired Renal Function
  • ELX-02
  • Miami, Florida
  • +1 more
Mar 19, 2021

Genetic Disease, Nonsense Mutation Trial in Antwerp (ELX-02, Placebo)

Completed
  • Genetic Disease
  • Nonsense Mutation
  • ELX-02
  • Placebo
  • Antwerp, Belgium
    SGS Life Sciences, Clinical Pharmacology Unit
Feb 23, 2021

Genetic Disease, Nonsense Mutation, Cystinosis Trial in Montréal (ELX-02)

Terminated
  • Genetic Disease
  • +2 more
  • ELX-02
  • MontrĂ©al, Quebec, Canada
    McGill University Health Center
May 22, 2020

Genetic Diseases, Nonsense Mutations Trial (ELX-02, Placebo)

Terminated
  • Genetic Diseases
  • Nonsense Mutations
  • ELX-02
  • Placebo
  • (no location specified)
Oct 19, 2019

Genetic Disease, Nonsense Mutation Trial in Antwerp (Placebo, ELX-02)

Completed
  • Genetic Disease
  • Nonsense Mutation
  • Placebo
  • ELX-02
  • Antwerp, Belgium
    SGS Life Sciences, Clinical Pharmacology Unit
Oct 19, 2019